Botulinum toxin treatment of secretory disorders

Movement Disorders

Volumn 19, Issue SUPPL. 8, 2004, Pages

  Naumann, Markus ^a,c   Jost, Wolfgang ^b  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b DEUTSCHE KLINIK FÜR DIAGNOSTIK   (Germany)

^c UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

Author keywords

Botulinum toxin; Focal hyperhidrosis; Hyperlacrimation; Parkinson's disease; Sialorrhea

Indexed keywords

BOTULINUM TOXIN A; BOTULINUM TOXIN B; CHOLINERGIC RECEPTOR BLOCKING AGENT; NEUROTOXIN; ANTIPARKINSON AGENT; BOTULINUM TOXIN;

AMYOTROPHIC LATERAL SCLEROSIS; ANHIDROSIS; ARTICLE; AUTONOMIC NEUROPATHY; AXILLA; CAROTID ARTERY INJURY; CLINICAL TRIAL; DOSE RESPONSE; DRUG COST; DRUG EFFICACY; DRUG SAFETY; DYSPHAGIA; EVIDENCE BASED MEDICINE; FACIAL NERVE INJURY; FREY SYNDROME; HAND; HEMATOMA; HUMAN; HYPERHIDROSIS; HYPERSALIVATION; INFECTION; INJECTION PAIN; LACRIMAL GLAND DISEASE; MUSCLE WEAKNESS; PALLIATIVE THERAPY; PARKINSON DISEASE; PILOT STUDY; PRIORITY JOURNAL; RHINORRHEA; RISK BENEFIT ANALYSIS; SALIVARY GLAND DISEASE; SWEAT GLAND DISEASE; XEROSTOMIA; INNERVATION; REVIEW;

ANTI-DYSKINESIA AGENTS; AXILLA; BOTULINUM TOXINS; HAND; HUMANS; HYPERHIDROSIS; PARKINSON DISEASE; SALIVARY GLAND DISEASES; SIALORRHEA;

EID: 3242780906     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/mds.20067     Document Type: Article

References (44)

1. Kerner J. Das Fettgift oder die Fettsäure und ihre Wirkungen auf den thierischen Organismus, ein Beytrag zur Untersuchung des in verdorbenen Würsten giftig wirkenden Stoffes. Stuttgart, Tübingen: Cotta. 1822.
2. Boroojerdi B, Ferbert A, Schwarz M, Herath H, Noth J. Botulinum toxin treatment of synkinesia and hyperlacrimation after facial palsy. J Neurol Neurosurg Psychiatry 1998;65:111-114.
3. Bushara KO, Park DM. Botulinum toxin and sweating. J Neurol Neurosurg Psychiatry 1994;57:1437-1438.
4. Chesire WP. Subcutaneous botulinum toxin type A inhibits regional sweating: an individual observation. Clin Auton Res 1996; 6:123-124.
5. Naumann M, Flachenecker P, Bröcker E-B, Toyka KV, Reiners K. Bondinum toxin for palmar hyperhidrosis. Lancet 1997;349:252.
6. Schnider P, Binder M, Auff E, Kittler H, Berger T, Wolff K. Double-blind trial of botulinum toxin for the treatment of focal hyperhidrosis of the palms. Br J Neurol 1997;136:548-552.
7. Naumann M, Hofmann U, Bergmann I, Hamm H, Toyka KV, Reiners K. Focal hyperhidrosis: effective treatment with intracutaneous botulinum toxin. Arch Dermatol 1998;134:301-304.
8. Naumann M, Bergmann I, Hofmann U, Hamm H, Reiners K. Botulinum toxin for focal hyperhidrosis: technical considerations and improvements of application. Br J Dermatol 1998;139:1123-1124.
9. Odderson IR. Axillary hyperbidrosis: treatment with botulinum toxin A. Arch Phys Med Rehabil 1998;79:350-352.
10. Naumann M, Hamm H, Kinkelin I, Reiners K. Botulinum toxin type A in the treatment of focal, axillary and palmar hyperbidrosis and other hyperhidrotic conditions. Eur J Neurol 1999;6:S111-S115.
11. Schnider P, Binder M, Kittler H, Birner P, Starkel D, Wolff K, Auff E. A randomized, double-blind, placebo-controlled trial of botulinum toxin for severe axillary hyperhidrosis. Br J Dematol 1999;140:677-680.
12. Shelley WB, Talanin NY, Shelley ED. Botulinum toxin therapy for palmar hyperhidrosis. J Am Acad Dermatol 1998;38:227-229.
13. Naumann M, Jost W, Toyka KV. Botulinum toxin in the treatment of neurological disorders of the autonomic nervous system. Arch Neurol 1999;56:914-916.
14. Glogau RG. Botulinum A neurotoxin for axillary hyperhidrosis. Dermotol Surg 1998;24:817-819.
15. Naver H, Swartling C, Aquilonius S. Treatment of focal hyperhidrosis with botulinum toxin type A. Brief overview of methodology and 2 years' experience. Eur J Neurol 1999;6:S117-S120.
16. Heckmann M, Breit S, Ceballos-Baumann A, et al. Side-controlled intradermal injection of botulinum toxin A in recalcitrant axillary hyperhidrosis. J Am Acad Dermatol 1999;41:987-990.
17. Solomon B, Hayman R. Botulinum toxin type A therapy for palmar and digital hyperhidrosis. J Am Acad Dermatol 2000;42:1026-1029.
18. Karamfilov T, Konra H, Karte K, Wollina U. relapse rate of botulinum toxin A therapy for axillary hyperhidrosis by dose increase. Arch Dermatol 2000;136:487-490.
19. Naver H, Swartling C, Aquilonius S-M. Palmar and axillary hyperhidrosis treated with botulinum toxin: one-year clinical follow-up. Eur J Neurol 2000;7:55-62.
20. Naumann M, Lowe N, for the hyperhidrosis study group. A randomized, placebo-controlled, double-blind study of botulinum toxin type A in bilateral axillary hyperbidrosis. BMJ 2001;323: 596-599.
21. Heckmann M, Ceballos-Baumann A, Plewig G. Botulinum toxin A for axillary hyperhidrosis (excessive sweating). N Engl J Med 2001;344:488-493.
22. Naumann M, Hamm H, Lowe N. Effect of botulinum toxin type A on quality of life measures in patients with excessive axillary sweating: a randomized controlled trial. Br J Dermatol 2002;147: 1218-1226.
23. Naumann M, Lowe NJ, Kumar CR, Hamm H. Botulinum toxin type A is a safe and effective long-term treatment for axillary hyperbidrosis. Arch Dermatol 2003;139:731-736.
24. Dressler D, Adib Saberi F, Benecke R. Botulinum toxin type B for treatment of axillar hyperhidrosis. J Neurol 2002;249:1729-1732.
25. Böger A, Herath H, Rompel R, Ferbert A. Botulinum toxin for treatment of craniofacial hyperhidrosis. J Neurol 2000;415:857-861.
26. Kinkelin I, Hund M, Naumann M, Hamm H. Effective treatment of frontal hyperhidrosis with botulinum toxin A. Br J Dermatol 2000; 143:824-827.
27. Bergmann I, Dauphin M, Naumann M, Flachenecker P, Müllges W, Koltzenburg M, Sommer C. Selective degeneration of sudomotor fibers in Ross syndrome and successful treatment of compensatory hyperbidrosis with botulinum toxin. Muscle Nerve 1998; 1790-1793.
28. Drobik C, Laskawi R. Frey's syndrome: treatment with botulinum toxin. Acta Otolaryngol 1995;115:459-461.
29. Naumann M, Zellner M, Toyka KV, Reiners K. Treatment of gustatory sweating with botulinum toxin. Ann Neurol 1997;42: 973-975.
30. Bjerkhoel A, Trobbe O. Frey's syndrome: treatment with botulinum toxin. J Laryngol Otol 1997;111:839-844.
31. Laskawi R, Drobik C, Schönebeck C. Up-to-date report of botulinum toxin type A treatment in patients with gustatory sweating (Frey's syndrome). Laryngoscope 1998;108:381-384.
32. Laccourreye O, Akl E, Gutierrez-Fonseca R, Garcia D, Brasnu D, Bonan B. Recurrent gustatory sweating (Frey syndrome) after intracutaneous injection of botulinum toxin type A. Arch Otolaryngol Head Neck Surg 1999;125:282-286.
33. Giess R, Naumann M, Werner E, Riemann R, Beck M, Puls I, Reiners C, Toyka KV. Injections of botulinum toxin into the salivary gland improve sialorrhea in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 2000;69:121-123.
34. Shaari CM, Wu BL, Biller HF, Chuang SK, Sanders I. Botulinum toxin decreases salivation from canine submandibular glands. Otolaryngol Head Neck Surg 1998;118:452-457.
35. Ellies M, Laskawi R, Götz W, Arglebe C, Tormählen G. Immunohistochemical and morphometric investigations of the influence of botalinum toxin on the submandibular gland of the rat. Eur Arch Otorhinolaryngol 1999;256:148-152.
36. Porta M, Gamba M, Bertacchi G, Vaj P. Treatment of sialorrhea with ultrasound guided botulinum toxin type injection in patients with neurological disorders. J Neurol Neurosurg Psychiatry 2001; 70:538-540.
37. Bhatia KP, Münchau A, Brown P. Botulinum toxin is a useful treatment in excessive drooling of saliva [letter]. J Neurol Neurosurg Psychiatry 1999;67:697.
38. Pal PK, Calne DB, Calne S, Tsui JK. Botulinum toxin A as treatment for drooling saliva in PD. Neurology 2000;54:244-247.
39. Jost W. Treatment of drooling in Parkinson's disease with botulinum toxin [letter]. Mov Disord 1999;14:1057-1059.
40. Boroojerdi B, Ferbert A, Schwarz M, Noth J. Botulinum toxin treatment of synkinesia and hyperlacrimation after facial palsy. J Neurol Neurosurg Psychiatry 1998;65:111-114.
41. Riemann R, Pfenningsdorf S, Riemann E, Naumann M. Successful treatment of crocodile tears by injection of botulinum toxin into the lacrimal gland. Ophthalmology 1999;106;2322-2324.
42. Hofmann RJ. Treatment of Frey's syndrome (gustatory sweating) and crocodile tears (gustatory epiphora) with purified botulinum toxin. Ophthal Plast Reconstr Surg 2000;16:289-291.
43. Meyer M. Krokodilstränen und ihre Behandlung. In: Laskawi R, Roggenkämper P, editors. Botulinumtoxin-Therapie im Kopf-Hals-Bereich. München: Urban and Vogel; 1999. p 245-255.
44. Kim K, Kim S, Yoon J, Han J. The effect of botulinum toxin type A injection for intrinsic rhinitis. J Laryngol Otol 1998;112:248-251.